Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Gross ProfitOther Operating ExpensesRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed N.V (MYNZ) EBIT: 2019-2024

Historic EBIT for Mainz Biomed N.V (MYNZ) over the last 6 years, with Dec 2024 value amounting to -$18.7 million.

  • Mainz Biomed N.V's EBIT rose 21.44% to -$6.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$26.6 million, marking a year-over-year decrease of 0.76%. This contributed to the annual value of -$18.7 million for FY2024, which is 29.83% up from last year.
  • As of FY2024, Mainz Biomed N.V's EBIT stood at -$18.7 million, which was up 29.83% from -$26.6 million recorded in FY2023.
  • In the past 5 years, Mainz Biomed N.V's EBIT registered a high of -$673,715 during FY2020, and its lowest value of -$26.6 million during FY2023.
  • Moreover, its 3-year median value for EBIT was -$26.4 million (2022), whereas its average is -$23.9 million.
  • As far as peak fluctuations go, Mainz Biomed N.V's EBIT plummeted by 1,343.43% in 2021, and later increased by 29.83% in 2024.
  • Over the past 5 years, Mainz Biomed N.V's EBIT (Yearly) stood at -$673,715 in 2020, then tumbled by 1,343.43% to -$9.7 million in 2021, then plummeted by 171.93% to -$26.4 million in 2022, then fell by 0.76% to -$26.6 million in 2023, then rose by 29.83% to -$18.7 million in 2024.